Regulation of megakaryocytopoiesis

Haemostasis

Volumn 29, Issue 1, 1999, Pages 27-40

  Caen, J P ^a   Han, Z C ^b   Bellucci, S ^a   Alemany, M ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

^b INSTITUTE OF HEMATOLOGY AND BLOOD DISEASES HOSPITAL   (China)

Author keywords

Cytokines; Megaka ryocytopoiesis; Platelet factor 4; Thrombopoiesis; Thrombopoietin

Indexed keywords

ALPHA INTERFERON; ANAGRELIDE; CHEMOKINE; CYTOKINE; MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR; THROMBIN; THROMBOCYTE FACTOR 4; THROMBOPOIETIN; TRANSFORMING GROWTH FACTOR BETA1;

BLEEDING; BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CONFERENCE PAPER; CYTOTOXICITY; HUMAN; MEGAKARYOPOIESIS; NONHUMAN; PRIORITY JOURNAL; PROTO ONCOGENE; THROMBOCYTE DISORDER; THROMBOCYTOPENIA; THROMBOCYTOPOIESIS; THROMBOSIS;

EID: 0344549405     PISSN: 03010147     EISSN: None     Source Type: Journal    
DOI: 10.1159/000022458     Document Type: Conference Paper

References (81)

1. Caen JP, Han ZC: Control of megakaryocyte development: From basic data to clinical results. CR Acad Sci III 1993;316:925-930.
2. Wendung F, Han ZC: Positive and negative regulation of megakaryocytopoiesis; in Caen JP, Han ZC (eds): Megakaryocyte and platelet disorders. Bailliere's Clinical Haematology 1997;10:29-45.
3. 1.B J Haematol 1992;81:1-5.
4. Carrington PA, Hill RJ, Levin J, Verotta D: Effects of interleukin 3 and interleukin 6 on platelet recovery in mice treated with 5-fluorouracil. Exp Haematol 1992;20:462-469.
5. Donahue RE, Seehra J, Metzger M, Lefevre D, Rock B, Carbone S, Nathan DG, Garnick M, Sehgal PK, Laston D: Human IL-3 and GM-CSF act synergistically in stimulating hematopoiesis in primates. Science 1988;241:1820-1823.
6. Geissler K, Valent P, Batteheim P, Sillaber C, Wagner B, Kyrle P, Hinterberger W, Lechner K, Liehl E, Mayer P: In vivo synergism of recombinant human interleukin-3 and recombinant human interleukin-6 on thrombopoiesis in primates. Blood 1992;79:1155-1160.
7. Yonemura Y, Kawakita M, Masuda T, Fujimoto K, Kato K, Takatsuki K: Synergistic effects of interleukin 3 and interleukin 11 on murine megakaryocytopoiesis in serum-free culture. Exp Hematol 1992;20: 1011-1016.
8. Bruno E. Briddell RA, Cooper RJ, Brandt JE, Hoffman R: Recombinant GM-CSF/IL3 fusion protein. Its effects on in vitro human megakaryocytopoiesis. Exp Hematol 1992;20:494-499.
9. Ishibashi T, Kimura H, Shikama Y, Uchida T, Kariyone S, Hiranot T, Kishimoto T, Takatsuki F, Akiyama Y: Interleukin-6 is a potent thrombopoietic factor in vitro in mice. Blood 1989;74:1241-1244.
10. Asano S, Okano A, Ozawa K, Nakawata T, Ishibashi T, Koike K. Kimura H, Tanioka Y, Shibuya A, Hirano T, et al: In vivo effects on recombinant human interleukin-6 in primates: Stimulated production of platelets. Blood 1990;75:1602-1606.
11. Bruno E, Briddell RA, Cooper RJ, Hoffman R: Effect of recombinant interleukin-11 on human megakaryocyte progenitor cells. Exp Hematol 1991;19:378-381.
12. Teramura M, Kobayashi S, Hoshino S, Oshimi K, Mizoguchi H: Interleukin-11 enhances human megakaryocytopoiesis in vitro. Blood 1992;79: 327-331.
13. Burstem SA. Mei RL, Henthorn J, Friese P, Turner K: Leukemia inhibitory factor and interleukin-11 promote maturation of murine and human megakaryocytes in vitro.
14. Yonemura Y, Kawakita M, Masuda T, Fujimoto K, Takatsuki K: Effect of recombinant human interleukin-11 on rat megakaryopoiesis and thrombopoiesis in vivo: Comparative study with interleukin-6. Br J Haematol 1993;84:16-23.
15. Hangoc G, Yin T, Cooper S, Schendel P, Yang YC. Broxmeyer HE: In vivo effects of recombinant interleukin-11 on myelopoiesis in mice. Blood 1993;81:965-972.
16. Ishibashi T, Kimura H, Shikama Y, Uchida T, Kariyone S, Maruyama Y: Effect of recombinant granulocy-to-macrophage colony-stimulating factor on murine thrombocytopoiesis in vitro and in vivo. Blood 1990; 75:1433-1438.
17. Vannucchi AM, Grossi A. Rafanelli D, Ferrini R: In vivo stimulation of megakaryocytopoiesis by recombinant murine granulocyte-macrophage colony-stimulating factor. Blood 1990;76:1473-1480.
18. Kimura H, Ishibashi T, Shikama Y, Okano A, Akiyama Y, Uchida T. Maruyama Y: Interleukin-1β (IL-1β) induces thrombocytosis in mice: Possible implication of IL-6. Blood 1990;76:2493-2500.
19. Tewari A. Buhles WC, Starnes HF: Preliminary report: Effects of interleukin-1 on platelets. Lancet 1990; 336:712-714.
20. Avraham H, Vannier E, Cowley S, Jiang SX, Chi S, Dinarello CA, Zsebo KM, Groopman JE: Effects of the stem cell factor, c-kit ligand, on human megakaryocytic cells. Blood 1992;79:365-371.
21. Tanaka R, Koike K, Imai T, Shiohara M. Kubo T, Amano Y, Komiyama A. Nakahata T: Stem cell factor enhances proliferation, but not maturation, of murine megakaryocytic progenitors in serum-free culture. Blood 1992;80:1743-1749.
22. Hunt P, Zsebo KM, Hokom MM, Hornkohl A. Birkett NC, Del Castillo JC, Martin F: Evidence that stem cell factor is involved in the rebound thrombocytosis that follows 5-fluorouracil treatment. Blood 1992;80: 904-911.
23. Shikama Y, Ishibashi T, Kimura H, Kawaguchi M, Uchida T, Maruyama Y: Transient effect of erythropoietin on thrombocytopoiesis in vivo in mice. Exp Hematol 1992;20: 216-222.
24. Metcalf D, Hilton D, Nicola NA: Leukemia inhibitory factor can potentiate murine megakaryocyte production in vitro. Blood 1991;77: 2150-2153.
25. Bikfalvi A. Han ZC, Fuhrmann G: Interaction of fibroblast growth factor (FGF) with megakaryocytopoiesis and demonstration of FGF receptor expression in megakaryocytes and megakaryocytic-like cells. Blood 1992;80:1905-1913.
26. Armstrong E, Vainikka S, Partanen J, Korhonen J, Alitalo R: Expression of fibroblast growth factor receptors in human leukemia cells. Cancer Res 1992;52:2004-2007.
27. Han ZC, Maurer AM, Bellucci S, Wan HY, Kroviarski Y, Bertrand O, Caen JP: Inhibitory effect of platelet factor 4 (PF4) on the growth of human erythroleukemia cell: Proposed mechanism of action of PF4. J Lab Clin Med 1992;120:645-660.
28. Souyri M, Vigon I, Penciolelli JF, Heard JM, Tambourin P, Wendung F: A putative truncated receptor gene transduced by the myeloproliferative leukemia virus immortalizes hematopoietic progenitors. Cell 1990;63:1137-1147.
29. Methia N, Louache F, Vainchenker W, Wendung F: Oligonucleotides antisense to the proto-oncogene c-mpl specifically inhibit in vitro megakaryocytopoiesis. Blood 1993; 82:1395-1401.
30. Debili N, Massé JM, Katz A, Guichard J, Breton-Gorius J, Vainchenker W: Effects of recombinant hematopoietic growth factors (IL-3, IL-6, SCF, LIF) on the megakaryocyte differentiation of CD34 positive cells. Blood 1993;82:84-95.
31. Gurney AL, Carver-Moore K, de Sauvage FJ, Moore MW: Thrombocytopenia in c-mpl-deficient mice. Science 1994;265:1445-1447.
32. Hartley TD, Bogenberger J, Hunt P, Li YS, Lu HS, Martin F, Chang HS, Samal B, Nichol JL, Swift S, et al: Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor mpl. Cell 1994;77: 1117-1124.
33. de Sauvage FJ, Mass PE, Spencer SD, Malloy BE, Gurney AL, Spencer SA, Darbone WC, Henzel WJ, Wong SC, Kuang WJ, et al: Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand. Nature 1994;369:533-538.
34. Lok S, Kaushansky K, Holly RD, Kuijper JL, Lofton-Day CE, Oort PJ. Grant FJ, Heipel MD, Burkhead SK. Kramem JM, et al: Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo. Nature 1994; 369:565-568.
35. Katoh T, Ogami K, Shimada Y, Iwamatsu A, Sohma Y, Akahori H, Horie K, Kokubo A, Kudo Y, Maeda E: Purification and characterization of thrombopoietin. J Biochem 1995;118:229-236.
36. Kuter DJ, Beeler DL, Rosenberg RD: The purification of megapoietin: A physiological regulator of megakaryocyte growth and platelet production. Proc Natl Acad Sci (USA 1994;91:11104-11108.
37. Kaushansky K: Thrombopoietin: The primary regulator of platelet production. Blood 1995;86:419-431.
38. Wendung F, Marakovsky E, Debili N, Florindo C, Teepe M, Tileux M, Methia N, Breton-Gorius J, Cosman D, Vainchenker W: C-Mpl ligand is a humoral regulator of megakaryocytopoiesis. Nature 1994;69:571-574.
39. Debili N, Wendung F, Katz A, Guichard J, Breton-Gorius J, Hunt P, Vainchenker W: The Mpl-ligand or thrombopoietin or megakaryocyte growth and development factor has both direct proliferative and differentiative activities on human megakaryocyte progenitors. Blood 1995; 86:2516-2525.
40. Choi ES, Nichol JL, Hokom MM, Hornkohl AC, Hunt P: Platelets generated in vitro from proplatelet-displaying human megakaryocytes are functional. Blood 1995;85:402-413.
41. Farese AM. Hunt P. Boone T, MacVittie TJ: Recombinant human megakaryocyte growth and development factor stimulates thrombocytopoiesis in normal nunhuman primates. Blood 1995;86:54-59.
42. Harker LA, Hunt P, Marzec UM, Kelly AB, Tomer A, Hanson SR, Stead RB: Regulation of platelet production and function by megakaryocyte growth and development factor in nonhuman primates. Blood 1996;87:1833-1844.
43. Basser RL, Rasko JE, Clarke K, Cebon J. Green MD, Hussein S, Alt C, Menchaca D, Tomita D. Marty J, Fox RM. Begley CG: Thrombopoietic effects of pegylated rccombinant human megakaryocyte growth and development factor (PEG-rHu MGDF) in patients with advanced cancer. Lancet 1996;348:1279-1281.
44. Fibbe WE, Heemskerk DPM, Laterveer L, Pruijt JF. Foster D, Kaushansky K, Willemze R: Accelerated reconstitution of platelets and erythrocytes after syngeneic transplantation of bone marrow cells derived from thrombopoietin pretreated donor mice. Blood 1995;86:3308-3313.
45. Farese AM, Hunt P, Grab LB, MacVittie TJ: Combined administration of recombinant human megakaryocyte growth and development factor and granulocyte colony-stimulating factor enhances multilineage hematopoietic reconstitution of nonhuman primates after radiation-induced marrow aplasia. J Clin Invest 1996;97:2145-2151.
46. van Willigen G, Franke B, Gort er G, Bos JL, Akkerman JWN: Thrombopoietin increases platelet sensitivity to α-thrombin via activation of the ERK2-CPLA2 pathway (abstract). ETRO/IVS Meeting, May 1998.
47. Fontcnay-Roupic M, Lopez I, Melle J. Duprez V, Dreyfus F, Levy-Toledano S: Cortactin translocation and tyrosine phosphorylation as a marker of cytoskcleton involvement in thrombopoictin-stimulated platelets (abstract). ETRO/IVS Meeting, May 1998.
48. Nagata Y, Muro Y, Todokoro K: Thrombopoiet in-induced polyploidization of bone marrow megakaryocytes is due to a unique regulatory mechanism in late mitosis. J Cell Biol 1997;139:449-457.
49. Choi ES, Hokom MM, Chen JL. Skrine J, Faust J, Nichol J, Hunt P: The role of megakaryocyte growth and development factor in terminal stages of thrombopoicsis. Br J Haematol 1996;95:227-233.
50. Pitcher L, Taylor K, Nichol J, Selsi D, Rodwell R, Marty J, Taylor D, Wright S, Moore D, Kelly C, Rentoul A: Thrombopoietin measurement in thrombocytosis: Dysregulation and lack of feedback inhibition in essential thrombocythaemia. Br .1J Haematol 1997;99:929-932.
51. Wiestner A, Schlemper RJ, van der Maas AP, Skoda RC: An activating splice donor mutation in the thrombopoietin gene causes hereditary thrombocythaemia. Nat Genet 1998;18:49-52.
52. Kaushansky K: Thrombopoietin: Understanding and manipulating platelet production. Annu Rev Med 1997;48:1-11.
53. Eaton DL, de Sauvage FJ: Thrombopoietin: The primary regulator of megakaryocytopoiesis and thrombopoiesis. Exp Hematol 1997;25:1-7.
54. Kimura S, Roberts AW, Metcalf D, Alexander WS: Hematopoietic stem cell deficiencies in mice lacking c-Mpl, the receptor for thrombopoiotin. Proc Natl Acad Sci USA 1998; 95:1195-1200.
55. Cwirla SE, Balasubramanian P, Duffin DJ, Wagstrom CR, Gates CM, Singer SC, Davis AM, Tansik RL, Mattheakis LC, Boytos CM, Schatz PJ, Baccanari DP, Wrighton NC. Barrett RW, Dower WJ: Peptide agonist of the thrombopoietin receptor as potent as the natural cytokine. Science 1997;276:1696-1699.
56. Caen JP, Han ZC: Megakaryocyte differentiation: Positive and negative regulation. Cell Res 1995; (suppl):23-31.
57. Gewirtz AM, Zhang J, Ratajczak J, Ratajczak M, Park KS, Li C, Van Z, Poncz M: Chemokine regulation of megakaryocytopoiesis. Blood 1995; 86:2559-2567.
58. Moses HL, Yang EY: TGF-β stimulation and inhibition of cell proliferation: New mechanistic insights. Cell 1990;63:245-247.
59. Kuter DJ, Gminski DM, Rosenberg RD: Transforming growth factor β inhibits megakaryocyte growth and endomitosis. Blood 1992;79:619-626.
60. Keller JR, Jacobsen SW, Sill KT, Elligsworth LR, Ruscetti FW: Stimulation of granulopoiesis by transforming growth factor β: Synergy with granulocyte/macrophage stimulating factor. Proc Natl Acad Sci USA 1991;593:326-333.
61. Xi XD, Caen JP, Fournier S, Schlegel N, Amiral J, Sibony O, Blot P, Han ZC: Direct and reversible inhibition of platelet factor 4 on megakaryocyte development from CD34+ cord blood cells: Comparative studies with transforming growth factor β1. Br J Haematol 1996;93:265-272.
62. Carlino JA, Higley HR, Avis RD, Ellingsworth LE: Hematologic and hematopoietic changes induced by systemic administration of TGFβ. Ann NY Acad Sci 1990;593:326-333.
63. Bursuker I, Nedeermann KM, Petty BA, Schalter B, Spitalny GL, Tepper MA, Pasternak RD: In vivo regulation of hemopoiesis by transforming growth factor beta 1: Stimulation of GM-CSF- and M-CSF-dependent murine bone marrow precursors. Exp Hematol 1992;20:431-435.
64. Baggiolini M, Deward B, Moser B: Interleukin-8 and related chemotactic cytokines - CXC and CC chemokines. Adv Immunol 1994;55:97-106.
65. Gewirtz AM, Calabretta B, Rucinski B, Niewiarowski S, Xu WY: Inhibition of human megakaryocytopoiesis in vitro by platelet factor 4 (PF4) and a synthetic COOH-terminal PF4 peptide. J Clin Invest 1989;83: 1477-1482.
66. Han ZC, Sensebe L, Abgrall JF, Briere J: Platelet factor 4 inhibits human megakaryocytopoiesis in vitro. Blood 1990;75:1234-1239.
67. Han ZC, Bellucci S, Tenza D, Caen JP: Negative regulation of human megakaryocytopoiesis by human platelet factor 4 and beta-thromboglobulin: Comparative analysis in bone marrow cultures from normal individuals and patients with essential thrombocythaemia and immune thrombocytopenic purpura. Br J Haematol 1990;74:395-401.
68. Han ZC, Bellucci S, Bodevin E, Wan HY, Shen ZX, Caen JP: In vivo inhibition of megakaryocyte and platelet production by platelet factor 4 in mice. CR Acad Sci III 1991;313:553-558.
69. Lebeurier I, Basara N, Aidoudi S, Amiral J, Caen JP, Han ZC: Carboxy-terminal peptides (C1-24 and C13-24 but not C1-13) of platelet factor 4 inhibit murinc megakaryocytopoiesis, an activity which is neutralized by heparin. Br J Haematol 1996;92:29-34.
70. Lecomte-Raclet L, Alemany M, Sequeira-Le Grand A, Amiral J. Quentin G, Vissac AM, Caen JP. Han ZC: New insights into the negative regulation of hematopoiesis by chemokine platelets factor 4 and related peptides. Blood 1998;91:2772-2780.
71. Maurer AM, Han ZC, Dhermy D, Brière J: Inhibitory effect of platelet factor 4 on human erythroleukemic cells is dependent on cell surface heparan sulfate. J Lab Clin Med 1996;127:382-390.
72. Rider C: The selective binding of interleukins to glycosaminoglycans. Leukemia 1993;7:777-778.
73. Man ZC, Bellucci S, Shen ZX, Maffrand JP, Pascal M, Petitou M, Lormeau J, Caen JP: Glycosaminoglycans enhance megakaryocytopoiesis by modifiying the activities of hematopoietic growth regulators. J Cell Physiol 1996;168:97-104.
74. Klagsbrun M, Baired A: A dual receptor system is required for basic fibroblast growth factor activity. Cell 1991;67:229-231.
75. Sato Y, Waki M, Ohno M, Kuwano M, Sakata T: Carboxyl-terminal heparin-binding fragments of platelet factor-4 retain the blocking effect on the receptor binding of basic fibroblast growth factor. Jpn J Cancer Res 1993;84:485-489.
76. Plantier JL, Berthier R, Rival Y, Schweitzer A, Rabiet MJ: Evidence for a selective inhibitory effect of thrombin on megakaryocyte progenitor growth mediated by the thrombin receptor. Br J Haematol 1994; 87:755-762.
77. Hunt P, Hokom MM, Wiemann B, Leven RM, Arakawa T: Megakaryocyte proplatelet-like process formation in vitro is inhibited by serum prothrombin, a process which is blocked by matrix-bound glycosaminoglycans. Exp Hematol 1993; 21:372-381.
78. Han ZC, Briere J, Abgrall JF, Le Gall G, Parent D. Sensebe L: Effects of recombinant human interferon alpha on human megakaryocyte and fibroblast colony formation. J Biol Regul Homeost Agents 1987;1:195-200.
79. Wadenvik H, Kutti J, Ridell B, Revesz P. Jacobsson S, Magnusson B, Westin J, Vilen L: The effect of α-interferon on bone marrow megakaryocytes and platelet production rate in essential thrombocythemia. Blood 1991;77:2103-2108.
80. Mazur EM, Rosmarin AG, Sohl PA, Newton JL, Narendran A: Analysis of the mechanism of anagrelide-induced thrombocytopenia in humans. Blood 1992;79:1931-1937.
81. Bellucci S, Legrand C, Boval B, Drouet L, Caen JP: Studies of platelet volume, chemistry and function in patients with essential thrombocythemia and treated with anagrelide. Br J Haematol 1999; 104:886-892.